CJC-1295 (without DAC) and Vesugen Interaction

Synergistic
Mechanism-based 47% confidence

CJC-1295 (without DAC) and Vesugen have a synergistic interaction with 47% confidence. CJC-1295 (without DAC) and Vesugen work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Vesugen

KED | Vascular Bioregulator Peptide

Vesugen works through epigenetic regulation by interacting with DNA promoter regions, particularly affecting Ki-67 gene expression which controls cell division. It plays a prominent role in regulating sirtuin 1 (SIRT1) protein levels - a key anti-aging protein activated during calorie restriction.

Half-life: Not established Typical dose: 10-20 mg per day (oral capsules) or 10 mg (injectable) longevity, healing
teratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Blood Vessels
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), Vesugen). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Vesugen?

Yes, CJC-1295 (without DAC) and Vesugen can generally be taken together. CJC-1295 (without DAC) and Vesugen work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.

Is CJC-1295 (without DAC) and Vesugen safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and Vesugen?

CJC-1295 (without DAC) and Vesugen work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and Vesugen?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Vesugen has a half-life of Not established. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs Vesugen

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.